Genome

DNA genome CRISPR gene editing

Rome's 'dark genome' drug reduces autoimmune markers in mice

Preclinical tests of Rome Therapeutics' drug show that it’s effective in reducing a type of inflammation believed to promote autoimmune disease.

Helen Floersh Nov 17, 2023 1:03pm

Francis Collins - NIH Director

Collins, after 12 years at the NIH helm, will exit

Oct 5, 2021 9:20am

3D medical background with DNA strand

Doudna's team identifies new 'hypercompact' CRISPR enzyme

Jul 16, 2020 2:00pm

ArsenalBio

ArsenalBio joins next-gen cell therapy field with $85M A round

Oct 17, 2019 7:00am

Rendering of Pfizer gene therapy facility

Sangamo Therapeutics bags Cytokinetics' exec as new CMO

Oct 1, 2019 7:45am

World Health Organization WHO

WHO panel pushes for genome editing research registry

Mar 20, 2019 9:50am